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Vincent W. V. Jaddoe, MD, PhD
FETAL DEVELOPMENTAL ADAPTA-tions due to adverse environ-mental exposures may affect thestructure, physiology, and func-
tion of various organ systems leading
to fetal growth restriction and in-
creased risks of metabolic and cardio-
vascular disease in adulthood.1,2 Hu-
man growth and development rates are
highest during the first trimester of
pregnancy, when essential fetal organ
development is completed.3 Adverse
first-trimester fetal exposures might
have permanent consequences for fe-
tal and postnatal health.
First-trimester fetal crown to rump
length is used in obstetric care prac-
tice for pregnancy dating, assuming
no growth variation.4 Studies among
women with a regular menstrual
cycle suggest that maternal age, eth-
nicity, and fetal sex are associated
with fetal crown to rump length.5,6
Maternal smoking, alcohol consump-
tion, and folic acid supplement use
influence birth weight,7,8 but their
associations with first-trimester fetal
growth are not known. Two studies
suggested that first-trimester fetal
growth restriction increases the risks
of low birth weight and small size for
gestational age.9,10 The relationship
between first-trimester fetal growth
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Context Adverse environmental exposures lead to developmental adaptations in fe-
tal life. The influences of maternal physical characteristics and lifestyle habits on first-
trimester fetal adaptations and the postnatal consequences are not known.
Objective To determine the risk factors and outcomes associated with first-
trimester growth restriction.
Design, Setting, and Participants Prospective evaluation of the associations of
maternal physical characteristics and lifestyle habits with first-trimester fetal crown
to rump length in 1631 mothers with a known and reliable first day of their last
menstrual period and a regular menstrual cycle. Subsequently, we assessed the
associations of first-trimester fetal growth restriction with the risks of adverse birth
outcomes and postnatal growth acceleration until the age of 2 years. The study was
based in Rotterdam, the Netherlands. Mothers were enrolled between 2001 and
2005.
MainOutcomeMeasures First-trimester fetal growth was measured as fetal crown
to rump length by ultrasound between the gestational age of 10 weeks 0 days and 13
weeks 6 days. Main birth outcomes were preterm birth (gestational age37 weeks),
low birth weight (2500 g), and small size for gestational age (lowest fifth birth cen-
tile). Postnatal growth was measured until the age of 2 years.
Results In the multivariate analysis, maternal age was positively associated with first-
trimester fetal crown to rump length (difference per maternal year of age, 0.79 mm;
95% confidence interval [CI], 0.41 to 1.18 per standard deviation score increase). Higher
diastolic blood pressure and higher hematocrit levels were associated with a shorter
crown to rump length (differences, −0.40 mm; 95% CI, −0.74 to −0.06 and −0.52
mm; 95% CI, −0.90 to −0.14 per standard deviation increase, respectively). Com-
pared with mothers who were nonsmokers and optimal users of folic acid supple-
ments, those who both smoked and did not use folic acid supplements had shorter
fetal crown to rump lengths (difference, −3.84 mm; 95% CI, −5.71 to −1.98). Com-
pared with normal first-trimester fetal growth, first-trimester growth restriction was
associated with increased risks of preterm birth (4.0% vs 7.2%; adjusted odds ratio
[OR], 2.12; 95% CI, 1.24 to 3.61), low birth weight (3.5% vs 7.5%; adjusted OR,
2.42; 95% CI, 1.41 to 4.16), and small size for gestational age at birth (4.0% vs 10.6%;
adjusted OR, 2.64; 95% CI, 1.64 to 4.25). Each standard deviation decrease in first-
trimester fetal crown to rump length was associated with a postnatal growth accel-
eration until the age of 2 years (standard deviation score increase, 0.139 per 2 years;
95% CI, 0.097 to 0.181).
Conclusions Maternal physical characteristics and lifestyle habits were indepen-
dently associated with early fetal growth. First-trimester fetal growth restriction was
associated with an increased risk of adverse birth outcomes and growth acceleration
in early childhood.
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restriction and postnatal health out-
comes remains unknown.
In a population-based prospective co-
hort study among mothers with a
known first day of the last menstrual
period, we examined the associations
of several maternal physical character-
istics and lifestyle habits with first-
trimester fetal growth. Subsequently, we
examined whether first-trimester fetal
growth restriction is associated with the
risks of adverse birth outcomes and
growth adaptations during fetal life and
early childhood.
METHODS
Study Design and Cohort
This study was embedded in the Gen-
eration R Study, a population-based
prospective cohort study from early fe-
tal life onward in Rotterdam, the Neth-
erlands.11 The study has been ap-
proved by the medical ethics committee
of the Erasmus Medical Center,
Rotterdam, the Netherlands. Written in-
formed consent for both maternal and
child data was obtained from all
mothers.
Mothers enrolled between 2001 and
2005. Fetal crown to rump length was
measured in 4195 mothers with single-
ton pregnancies (FIGURE 1). Of these
mothers, 3083 had measurements
within the recommended gestational
age range of 10 weeks 0 days and 13
weeks 6 days.12 Mothers who did not
undergo prenatal examinations within
this time frame (n=1112) and those in
whom pregnancy ended with miscar-
riage or stillbirth (n = 21) were ex-
cluded, since gestational age at time of
death with subsequent arrest of fetal
growth could not be ascertained.13
Mothers with neither a known first day
of the last menstrual period nor a regu-
lar menstrual cycle of 28 plus or mi-
nus 4 days were excluded (n=1431),
leaving 1631 participants for the analy-
ses. First day of the last menstrual pe-
riod was obtained from the referring
letter from the community midwife
or hospital. This date was confirmed
with the mother at the ultrasound
visit and additional information on
the regularity and cycle duration was
obtained.
The prevalence of preeclampsia and
(gestational) diabetes was 1.7% and
1.1%, respectively. Since exclusion of
these women did not materially change
our results, they were included in the
analyses.
Maternal Risk Factors
Information on maternal age, educa-
tional level, smoking habits, alcohol
use, folic acid supplement use, parity,
and mode of conception were ob-
tained through self-administered ques-
tionnaire at enrollment (response rate
93%). Since fetal growth is known to
vary between ethnicities,14 participat-
ing mothers were requested to give de-
tails regarding the country of birth of
their parents. This information was used
to classify participants’ ethnic back-
ground according to Statistics Nether-
lands, as previously described in de-
tail.14 Weight and height were measured
without shoes or heavy clothing and
body mass index was calculated (weight
in kilograms divided by height in me-
ters squared). Blood pressure was mea-
sured with the validated Omron 907
automated digital oscillometric sphyg-
momanometer (OMRON Healthcare
Europe B.V. Hoofddorp, the Nether-
lands). After being seated in an up-
right position for at least 5 minutes, the
mean value of 2 blood pressure read-
ings over a 60-second interval was
documented. Hematocrit and hemo-
globin levels were available from first-
trimester blood samples (success rate
84%).
Fetal Ultrasounds
In our research facility, we measured
first-trimester (14 weeks) crown to
rump length in a true midsagittal
plane with the genital tubercle and the
fetal spine longitudinally in view.15
The maximum length from cranium to
the caudal rump was measured as a
straight line. Transvaginal scanning
was performed in the case of limited
visibility by transabdominal scanning.
In the second trimester (median
weeks, 20.3; 90% range, 19.1-22.0),
and third (median weeks, 30.1; 90%
range, 29.0-32.0), we measured fetal
head circumference, biparietal diam-
eter, abdominal circumference, and
femur length to the nearest millimeter
using standardized ultrasound proce-
dures.16 Estimated fetal weight was
calculated using the formula by Had-
lock et al.17 Ultrasound examinations
were performed using an Aloka model
SSD-1700 (Tokyo, Japan) or the ATL-
Philips Model HDI 5000 (Seattle,
Washington).
Standard deviation scores for all
fetal growth characteristics were con-
structed.16 Intraclass correlation coef-
ficients for intraobserver and interob-
server reproducibility of crown to
rump length measurements were
0.998 and 0.995, respectively.18
Birth Outcomes
Date of birth, birth anthropometrics
(weight, length, head circumference)
and offspring sex were obtained from
community midwife and hospital
registries. Gestational age and sex-
adjusted standard deviation scores for
birth weight, length, and head circum-
Figure 1. Selection of Study Participants
1400 Newborns, infants, and children
included in postnatal analyses
4195 Women with singleton pregnancy
with fetal crown to rump length
measured
1618 Included in birth outcome analyses
1631 Included in risk factor analyses
1652 Enrolled during first trimester
13 Excluded (prenatal loss to
follow-up)
218 Excluded
115 Had residence outside
postnatal follow-up study
area
103 Postnatal loss to follow-up
2543 Excluded
1112 No prenatal examination
between 10 wk 0 d
gestation and 13 wk 6 d
1431 Unknown first day of last
menstrual period and/or
irregular menstrual cycle
21 Excluded for miscarriage
or stillbirth
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ference were constructed using growth
standards from Usher and McLean.19
Small size for gestational age at birth
was defined within our study popula-
tion (lowest fifth birth centile), pre-
term birth as a gestational age at birth
of less than 37 weeks, and low birth
weight as a birth weight of less than
2500 g.
Postnatal Growth
Well-trained staff in community health
centers obtained postnatal growth char-
acteristics (weight, length, and head cir-
cumference) using standardized pro-
cedures.11 Based on the routine health
care program, periodic visits were
scheduled for 8 age periods (1, 2, 3, 4,
6, 11, 14, and 24 months). Actual me-
dian (90% range) ages (by weeks) were:
4.7 (3.6-6.6); 9.7 (8.7-12.6); 14.4 (13.0-
16.9); 19.0 (17.4-21.2); 26.7 (23.7-
31.0); 47.6 (43.5-53.0); 61.8 (59.3-
68.2); and 107.1 (102.1-118.2). For
postnatal growth characteristics, we ob-
tained standard deviation scores using
Dutch reference growth curves (Growth
Analyzer 3.0, Dutch Growth Research
Foundation, Rotterdam, the Nether-
lands).
Statistical Analysis
First, we performed a nonresponse
analysis by comparing characteristics of
mothers who were included in the
analyses to those who were excluded
due to an unknown or unreliable first
day of last menstrual period or an ir-
regular menstrual cycle using the t,
Mann-WhitneyU, and2 tests. Also, we
compared birth characteristics of chil-
dren included in the postnatal analy-
ses to those who were not.
Second, we created gestational
age–adjusted standard deviation
scores for each individual fetal mea-
surement in our study (eAppendix,
available online at http://www.jama
.com). We used fetal sex and gesta-
tional age–adjusted linear regression
models to assess the associations of each
determinant with first-trimester fetal
crown to rump length separately. To en-
able comparison of the effect esti-
mates between risk factors, we pre-
sent our results as change per standard
deviation score for continuous vari-
ables. Subsequently, all factors associ-
ated with crown to rump length were
included in 1 multivariate linear re-
gression model. We also examined in-
teractions between lifestyle exposures
(smoking, alcohol use, and folic acid
supplement use). Since the timing of
ovulation is dependent of the dura-
tion of the menstrual cycle, these mod-
els were adjusted for the duration of the
last menstrual cycle.
Third, we examined the associa-
tions of first-trimester fetal growth re-
striction, defined as gestational age–
adjusted crown to rump length in the
lowest 20% of the population, with the
risk of adverse birth outcomes (pre-
term birth, small size for gestational age,
and low birth weight) using univari-
ate logistic regression models. To ac-
count for potential confounding, these
models were subsequently adjusted for
factors associated with fetal crown to
rump length.
Finally, we studied the associations
of first-trimester fetal crown to rump
length with growth characteristics in the
second and third trimesters and from
birth until the age of 24 months using
sex-adjusted linear regression mod-
els. To assess the associations of first-
trimester fetal crown to rump length
with longitudinally measured growth
rates in childhood, we performed un-
balanced repeated measures regres-
sion analysis (eAppendix).
With a sample size of 1631 women
and assuming a power of 0.80 and a
significance level of .05 (2-sided), we
were able to detect an effect of 0.07
standard deviations. When multiple
comparisons were performed, the
significance level was adjusted using
the Bonferroni correction. For all
ana lyses , miss ing va lues were
imputed with the mean for continu-
ous variables or an additional cat-
egory for categorical variables. We
found similar results based on
imputed and complete data sets. Sta-
tistical analyses were performed
using the Statistical Analysis System
version 9.1.3 (SAS Statistical Soft-
ware, Cary, North Carolina) and the
Statistical Package of Social Sciences
version 15.0 (SPSS Inc, Chicago, Illi-
nois).
RESULTS
Maternal and Fetal Characteristics
Maternal and fetal characteristics are
shown inTABLE 1. Nonresponse analy-
sis showed that mothers with a known
first day of the last menstrual period and
a reliable menstrual cycle were older,
more highly educated, more often
white, and more frequently users of fo-
lic acid supplements (all P .001)
(eTable 1, available at http://www.jama
.com). Of all newborns, infants, and
children, 7% were excluded from post-
natal follow-up studies because of re-
location outside of the study area and
6% were lost to follow-up for other rea-
sons. Postnatal follow-up data were
available in the remaining 87% of all
newborns, infants, and children in the
study. Those who were not included in
the postnatal analyses had a lower birth
weight (difference, 156 g; 95% CI, 61
to 251; P .001) and a smaller size for
gestational age at birth (difference, 0.50
weeks; 95% CI, 0.18 to 0.83; P=.009)
compared with those included in these
analyses (eTable 2).
Risk Factors of First-Trimester
Fetal Growth Variation
In the univariate analyses, higher ma-
ternal age, folic acid supplement use,
and having had a previous childbirth
were positively associated with fetal
crown to rump length (TABLE 2).
Higher diastolic blood pressure and he-
matocrit level, a secondary education
only, Surinamese ethnicity, and smok-
ing were associated with a shorter fe-
tal crown to rump length. Maternal an-
thropometrics were not associated with
fetal crown to rump length.
In the multivariate analyses, the as-
sociations of maternal age (0.10 stan-
dard deviation score; 95% CI, 0.05 to
0.16; P .001) per standard deviation
increase in age (1=4.68 years), dia-
stolic blood pressure (−0.05 standard
deviation score; 95% CI, −0.10 to −0.01;
P= .03) per standard deviation in-
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crease in blood pressure (1=9.52 mm
Hg), hematocrit level (−0.07 standard
deviation score; 95% CI, −0.12 to −0.01;
P=.02) per standard deviation increase
in hematocrit level (1=2.50%), smok-
ing (−0.13 standard deviation score;
95% CI, −0.25 to −0.01; P=.03), and fo-
lic acid supplement use (0.17 stan-
dard deviation score; 95% CI, 0.33 to
0.01; P=.03) with fetal crown to rump
length remained significant (TABLE 3).
After multiple testing adjustment (6 in-
dependent risk factors), the associa-
tions with diastolic blood pressure,
smoking, and folic acid supplement use
were no longer significant. We also ob-
served a dose-response association be-
tween the number of cigarettes smoked
daily by the mother and fetal crown to
rump length (P=.04). A stratified analy-
sis according to gestational age indi-
cated no interaction between gesta-
tional age and risk factors except for
maternal age, in which the effect size
increased with increasing gestational
age (P=.002; eTable 3).
We observed an interaction of
maternal smoking and folic acid
intake (P .001), indicating that
mothers who smoked and did not
use folic acid supplements had a
smaller fetal crown to rump length
growth (−0.52 standard deviation
score; 95% CI, −0.78 to −0.25; or
−3.84 mm; 95% CI, −5.71 to −1.98)
compared with nonsmoking mothers
who used folic acid supplements
(eFigure 2). We did not observe other
interactions between smoking, alco-
hol use, and folic acid supplement use
(all P .1).
First-Trimester Fetal Growth
Restriction and Adverse Birth
Outcomes
Small first-trimester fetal crown to
rump length, defined as the lowest
20%, was associated with an increased
risk of being born preterm (4.0% vs
7.2%), small size for gestational age
(4.0% vs 10.6%), or with a low birth
weight (3.5% vs 7.5%) (TABLE 4).
Using the same data, sensitivity analy-
ses with a cutoff of the lowest 10%
instead of the lowest 20% for crown
to rump length showed similar effect
estimates for preterm birth (4.2% vs
8.8%; odds ratio [OR], 2.43; 95% CI,
1.28 to 4.59; P=.006), small size for
gestational age at birth (4.5% vs
12.5%; OR, 2.50; 95% CI, 1.42 to
4.41; P=.001), and low birth weight
(3.7% vs 9.4%; OR, 2.70; 95% CI,
1.43 to 5.09; P=.002).
First-Trimester Fetal Growth
Restriction and Growth
in Fetal Life and Early Childhood
First-trimester fetal crown to rump
length was positively associated with
second- and third-trimester head cir-
cumference, femur length, and esti-
mated fetal weight (FIGURE 2). The
associations of first-trimester fetal
crown to rump length with biparietal
diameter and abdominal circumfer-
ence are shown in eTable 4. First-
trimester crown to rump length was
associated with postnatal weight until
the age of 11 months (0.061 standard
deviation score; 95% CI, 0.005 to 0.117;
P = .03) and with postnatal head
circumference and femur length until
Table 1. Maternal and Fetal Characteristics (N = 1631)
Characteristic Value
Maternal
Age at intake, median (90% range), y 31.4 (21.9-37.9)
Gestational age at intake, mean (SD), wk 12.4 (0.8)
Height, mean (SD), cm 169 (7.0)
Weight, median (90% range), kg 67.0 (53.0-92.5)
Body mass index, median (90% range)a 23.5 (19.4-32.0)
Blood pressure at intake, mean (range), mm Hg
Systolic 117 (12.4)
Diastolic 69 (9.5)
Hematocrit level, mean (SD), % 36.7 (2.5)
Hemoglobin level, mean (SD), g/dL 12.4 (0.9)
Education, No. (%)
Primary 93 (6.0)
Secondary 617 (39.6)
Higher 847 (54.4)
Race/ethnicity, No. (%)
Dutch/white 1127 (71.6)
Surinamese 88 (5.6)
Turkish 97 (6.2)
Moroccan 56 (3.6)
Indonesian 48 (3.0)
Other 158 (10.0)
Smoking, No. (%) 355 (24.3)
Alcohol use, No. (%) 888 (60.5)
Folic acid supplement use, No. (%) 1117 (85.1)
Parity, No. primiparous (%) 962 (59.3)
Conception, No. spontaneous (%) 1552 (98.9)
Fetal
First trimester crown to rump length, mm 60.9 (11.4)
Male sex, No. (%) 817 (50.5)
Birth head circumference, mean (SD), cm 34.0 (1.7)
Birth length, mean (SD), cm 50.4 (2.4)
Birth weight, mean (SD), g 3454 (565)
Gestational age at birth, median (90% range), wk 40.1 (37.1-42.0)
Preterm birth (37 wk), No. (%) 75 (4.6)
Small for gestational age (fifth birth centile), No. (%) 86 (5.3)
Low birth weight (2500 g), No. (%) 69 (4.3)
SI conversion factors: To convert hematocrit to proportion of 1.0, multiply by 0.01; hemoglobin to g/L, multiply by 10.
aCalculated as weight in kilograms divided by height in meters squared.
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the age of 14 months (0.080 standard
deviation score; 95% CI, 0.012 to
0.148; P=.02 and 0.065 standard de-
viation score; 95% CI, 0.007 to 0.122;
P=.03, respectively). No associations
between crown to rump length and
growth parameters at the age of 2
years were found. In these children,
each standard deviation decrease in
first-trimester fetal crown to rump
length was associated with an acceler-
ated growth rate in weight and height
during the first 2 years (increase of
0.139 standard deviation score per
2 years; 95% CI, 0.097 to 0.181;
P .001 and 0.128 standard deviation
score per 2 years; 95% CI, 0.085 to
0.173; P .001, respectively). These as-
sociations were independent of birth
weight.
COMMENT
This study showed that maternal physi-
cal characteristics and lifestyle habits
are associated with first-trimester crown
to rump length as a measure of first-
trimester fetal growth. Shorter first-
trimester crown to rump length was as-
sociated with increased risks of preterm
birth, small size for gestational age at
birth, and low birth weight. Further-
Table 2. Maternal Risk Factors of First-Trimester Variation in Fetal Crown to Rump Length Adjusted for Fetal Sex and Gestational Age
(N = 1631)a
Risk Factor
Effect Size for Fetal
Crown to Rump
Length (95% CI), mm
P
Value
Effect Size for
Standard Deviation
Score (95% CI)
P
Value
Age at intake (1 SD = 4.68 y) 0.84 (0.51 to 1.18) .001 0.11 (0.06 to 0.16) .001
Height (1 SD = 7.07 cm) 0.17 (−0.17 to 0.50) .33 0.02 (−0.03 to 0.06) .50
Weight (1 SD = 12.42 kg) 0.09 (−0.25 to 0.42) .62 0.01 (−0.04 to 0.05) .85
Body mass index (1 SD = 4.08 units)b −0.01 (−0.35 to 0.33) .96 −0.01 (−0.06 to 0.04) .81
Blood pressure at intake, mean SD, mm Hg
Systolic (1 SD = 12.38) −0.31 (−0.64 to 0.02) .07 −0.05 (−0.09 to 0.002) .06
Diastolic (1 SD = 9.46) −0.44 (−0.77 to −0.10) .01 −0.06 (−0.11 to −0.01) .01
Hematocrit level (1 SD = 2.50%) −0.57 (−0.95 to −0.20) .003 −0.07 (−0.13 to −0.02) .008
Hemoglobin level (1 SD = 0.94 g/dL) −0.56 (−0.91 to −0.20) .002 −0.06 (−0.12 to −0.01) .01
Education
Primary 0.75 (−0.71 to 2.20) .31 0.11 (−0.10 to 0.31) .33
Secondary −0.76 (−1.47 to −0.06) .03 −0.10 (−0.26 to 0.01) .07
Higher 0 [Reference] 0 [Reference]
Race/ethnicity
Dutch/white 0 [Reference] 0 [Reference]
Surinamese −2.22 (−3.69 to −0.74) .003 −0.26 (−0.47 to −0.05) .02
Turkish −0.29 (−1.69 to 1.11) .68 −0.05 (−0.25 to 0.16) .65
Moroccan 1.23 (−0.58 to 3.04) .18 0.21 (−0.08 to 0.49) .11
Indonesian 1.30 (−0.65 to 3.25) .19 0.20 (−0.08 to 0.49) .15
Other 0.44 (−0.69 to 1.57) .45 0.0 (−0.08 to 0.24) .35
Smoking
No 0 [Reference] 0 [Reference]
Yes, all −1.20 (−2.01 to −0.34) .004 −0.16 (−0.28 to −0.05) .007
Yes, 5/d −0.91 (−1.97 to 0.16) .09 −0.13 (−0.28 to 0.02) .09
Yes, 5-9/d −0.83 (−2.26 to 0.62) .26 −0.12 (−0.32 to 0.09) .27
Yes, 10/d −1.74 (−3.38 to −0.10) .04 −0.21 (−0.44 to 0.03) .08
Alcohol
Yes 0.40 (−0.31 to 1.11) .27 0.05 (−0.05 to 0.15) .34
No 0 [Reference] 0 [Reference]
Folic acid supplement use
Yes 0 [Reference] 0 [Reference]
No −1.10 (−2.14 to −0.07) .04 −0.14 (−0.29 to 0.01) .06
Parity
0 0 [Reference] 0 [Reference]
1 0.83 (0.16 to 1.51) .02 0.11 (0.02 to 0.21) .02
Spontaneous conception
Yes 0 [Reference] 0 [Reference]
No −0.61 (−3.74 to 2.53) .70 −0.14 (−0.59 to 0.31) .55
Abbreviation: CI, confidence interval.
aValues are calculated as regression coefficients (95% CI) and their corresponding P values. For continuous variables, the effect estimates represent the change in fetal crown to
rump length (mm or standard deviation score) per increase of standard deviation of the risk factor. For categorical or dichotomous variables, the effect estimates represent the
difference in fetal crown to rump length compared with the reference group.
bCalculated as weight in kilograms divided by height in meters squared.
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more, shorter first-trimester crown to
rump length was associated with ac-
celerated growth rates in early child-
hood.
We used the first day of the last
menstrual period to determine gesta-
tional age at crown to rump length
measurement. To avoid misclassifica-
tion, we included only pregnant
women with a known and reliable
first day of the last menstrual period
and a regular menstrual cycle of
approximately 28 days. Misclassifica-
tion of gestational age might still be
an issue since the postconceptional
age at the time of ultrasound is
dependent on the timing of ovulation
and implantation, which we were
unable to measure. For example, the
duration of the follicular phase, after
which ovulation occurs, has been
shown to also be associated with sev-
eral maternal factors such as mater-
nal age and smoking.20 Furthermore,
dating of the last menstrual period
can be confounded by recall bias.21
However, all our results remained
after adjustment for the duration of
last menstrual cycle, which is highly
associated with the timing of ovula-
tion. Moreover, even with a known
and reliable last menstrual period, a
certain fraction of women with regu-
lar cycles have early or delayed ovu-
lation. Nonetheless, restriction to
participants who had a gestational
age based on last menstruation
within 7 days of a gestational age
based on crown to rump length
(93%) did not materially change our
effect estimates.
Mothers with a known and reliable
last menstrual period were on aver-
age older, taller, more likely to be
higher educated and Dutch, consume
alcohol, and use folic acid supple-
ments than those with an unreliable
menstrual cycle. Our effect estimates
would be biased if the associations
between risk factors and first-
trimester fetal growth would differ
between individuals included and
not included in the analysis. This
seems unlikely.22
Table 3. Maternal Risk Factors of First-Trimester Variation in Fetal Crown to Rump Length Using Multivariate Analysis (N = 1631)a
Risk Factor
Effect Size for Fetal
Crown to Rump Length
(95% CI), mm
P
Value
Effect Size for
Standard Deviation
Score (95% CI)
P
Value
Age at intake (1 SD = 4.68 y) 0.79 (0.41 to 1.18) .001 0.10 (0.05 to 0.16) .001
Diastolic blood pressure (1 SD= 9.52 mm Hg) −0.40 (−0.74 to −0.06) .02 −0.05 (−0.10 to −0.01) .03
Hematocrit level (1 SD = 2.50%)b −0.52 (−0.90 to −0.14) .006 −0.07 (−0.12 to −0.01) .02
Hemoglobin level (1 SD = 0.946 g/dL)b −0.52 (−0.89 to −0.16) .005 −0.06 (−0.11 to −0.01) .02
Smoking (no = reference)
Yes, all −0.98 (−1.79 to −0.16) .02 −0.13 (−0.25 to −0.01) .03
Yes, 5/d −0.62 (−1.67 to 0.42) .24 −0.08 (−0.23 to 0.07) .29
Yes, 5-9/d −0.66 (−2.09 to 0.76) .36 −0.09 (−0.30 to 0.11) .38
Yes, 10/d −1.25 (−2.87 to 0.36) .13 −0.14 (−0.38 to 0.09) .23
Folic acid supplement use (yes = reference)
No −1.33 (−2.41 to −0.24) .02 −0.17 (−0.33 to −0.01) .03
Parity (0 = reference)
1 0.27 (−0.43 to 0.97) .45 0.04 (−0.06 to 0.14) .57
Abbreviation: CI, confidence interval.
aValues are calculated as regression coefficients (95% CI) and their corresponding P values. For continuous variables, the effect estimates represent the change in fetal crown to
rump length (mm or standard deviation score) per increase of standard deviation of the risk factor. For categorical or dichotomous variables, the effect estimates represent the
difference in fetal crown to rump length compared with the reference group. Variables included in the model: duration of last menstrual cycle, gestational age, fetal sex, age of
mother at intake, blood pressure, hematocrit level, educational level, race/ethnicity, smoking status, folic acid use, and parity.
bHematocrit and hemoglobin levels were added independently into the model due to the high correlation between these 2 risk factors.
Table 4. Associations of First Trimester Fetal Growth Restriction With Adverse Birth Outcomes (N = 1631)
Crown to Rump Length
Unadjusted OR
(95% CI)a
P
Value
Adjusted OR
(95% CI)a
P
Value20th Percentile, No. (%) 20th Percentile, No. (%)
Preterm birth
37 wk 23 (7.2) 52 (4.0) 1.85 (1.11-3.07) .02 2.12 (1.24-3.61) .006
37 wk 298 (92.8) 1245 (96.0)
Small size for gestational age
Fifth birth centile 34 (10.6) 52 (4.0) 2.84 (1.81-4.45) .001 2.64 (1.64-4.25) .001
Fifth birth centile 287 (89.4) 1245 (96.0)
Low birth weight
2500 g 24 (7.5) 45 (3.5) 2.24 (1.35-3.75) .002 2.42 (1.41-4.16) .001
2500 g 297 (92.5) 1252 (96.5)
Abbreviations: CI, confidence interval; OR, odds ratio.
aOdds ratios were based on multiple logistic regression models. Variables included in the model: duration of last menstrual cycle, fetal sex, age of mother at intake, educational
level, race/ethnicity, parity, diastolic blood pressure, hematocrit level, smoking status, and folic acid supplement use.
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Children lost to follow-up were on
average smaller at birth, which is a risk
factor for postnatal growth accelera-
tion.23 This might have led to an un-
derestimation of the postnatal growth
rates in children with first-trimester fe-
tal growth restriction. Restricting the
analyses on birth outcomes to those
children with complete fetal and post-
natal data did not materially change the
associations with the risks of adverse
birth outcomes.
Birth weight is the end point of dif-
ferent fetal growth patterns and ad-
verse exposures that may influence fe-
tal growth as early as the first trimester.
Previous studies suggested that mater-
nal age, black race, and male sex are as-
sociated with longer first-trimester
crown to rump length.5,6 We found
negative associations of higher dia-
stolic blood pressure and hematocrit
with first-trimester crown to rump
length. Higher blood pressure in early
pregnancy is known to be associated
with an increased risk of developing pla-
centa-related problems such as pre-
eclampsia and fetal growth restriction
in later pregnancy.24 A possible expla-
nation is that higher hematocrit levels
are indicative of a lower circulating
plasma volume, which subsequently
might lead to a suboptimal placental
perfusion.25 Finally, maternal anthro-
pometrics were not associated with first-
trimester crown to rump length, indi-
cating that the previously found
associations between maternal weight
and birth weight develop in later preg-
nancy.26
Smoking and the nonuse of folic
acid supplements were associated
with shorter first-trimester growth.
Folic acid serves as a substrate for
various cellular processes such as cell
division and apoptosis, which are
implicated in fetal and placental
growth and development.27 Further-
more, both smoking and folic acid
seem to be involved in DNA methyl-
ation, which may subsequently affect
early fetal and postnatal growth.28
There was a strong additive interac-
tion between smoking and folic acid
supplement intake. Jauniaux et al29
described that folic acid levels in
serum levels and coelomic fluid were
lower in smokers than nonsmokers,
suggesting that smoking may lead to
an impaired bioavailability of folic
acid. Smoking during pregnancy also
induces morphological and func-
tional changes in the placenta, lead-
ing to a reduction of fetal-placental
blood flow.30 Further studies on the
effects of these lifestyle factors on
early markers of abnormal placenta-
tion, such as pregnancy-associated
plasma protein A and free human
chorionic gonadotropin-, will allow
us to examine in greater detail what
role placental function plays in the
relationship between these factors
and early fetal growth.31
First-trimester fetal growth restric-
tion was associated with increased risks
of prematurity, small size for gesta-
tional age at birth, and low birth weight,
which are associated with increased
perinatal mortality and morbidity.
These findings are consistent with re-
sults from 2 previous studies, one in
spontaneously conceived pregnancies
and the other in pregnancies resulting
from assisted reproductive technol-
ogy.9,10 Shorter first-trimester crown to
rump length may be an intermediate in
the pathway between adverse mater-
nal risk factors, such as smoking and
nonuse of folic acid supplements, and
growth variation in later pregnancy and
possibly later life.32
Our results indicate that first-
trimester growth variation is associ-
ated with growth parameters in early
childhood. Smaller first-trimester fe-
tal crown to rump length led to com-
pensatory accelerated postnatal growth.
Subsequently, at the age of 24 months
there was no longer an association be-
tween fetal growth restriction and post-
natal growth parameters. Increased
postnatal growth rate is a well-
established risk factor for metabolic and
cardiovascular disease in later life.23,33
It could be that growth as early as in
the first trimester of pregnancy is as-
sociated with disease in adulthood, al-
though longer follow-up studies are
necessary to examine this relation-
ship.
In conclusion, our study demon-
strates that first-trimester fetal growth
is associated with several maternal
physical characteristics and lifestyle
habits. First-trimester growth restric-
tion is associated with higher risks of
adverse birth outcomes and acceler-
ated postnatal growth rates. Further
studies are needed to assess the asso-
ciations of first-trimester growth varia-
tion on the risks of disease in later child-
hood and adulthood.
Figure 2. Associations of First-Trimester Fetal Crown to Rump Length With Growth
Characteristics in Later Pregnancy and Early Childhood
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Values are regression coefficients (error bars indicate 95% confidence intervals) and represent the change (stan-
dard deviation score) of head circumference, femur length, and estimated fetal weight per increase of 1 stan-
dard deviation in first-trimester fetal crown to rump length. All models are adjusted for fetal sex. Head cir-
cumference was not available at 24 months of age.
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